116
Participants
Start Date
October 31, 2005
Study Completion Date
July 31, 2007
Lopinavir/ritonavir
Beth Israel Med. Ctr., ACTU, New York
NY Univ. HIV/AIDS CRS, New York
Univ. of Rochester ACTG CRS, Rochester
University of Pittsburgh CRS, Pittsburgh
Penn Therapeutics, CRS, Philadelphia
Georgetown University CRS (GU CRS), Washington D.C.
Johns Hopkins University CRS, Baltimore
Chapel Hill CRS, Chapel Hill
The University of Miami AIDS Clinical Research Unit (ACRU) CRS, Miami
Vanderbilt Therapeutics (VT) CRS, Nashville
Ohio State University CRS, Columbus
MetroHealth CRS, Cleveland
Cincinnati CRS, Cincinnati
Cook County Hosp. CORE Ctr., Chicago
Rush University CRS, Chicago
University of Colorado Hospital CRS, Aurora
UCLA CARE Center CRS, Los Angeles
Harbor-UCLA CRS, Torrance
UCSD Antiviral Research Center CRS, San Diego
Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu
University of Southern California CRS, Los Angeles
Stanford AIDS Clinical Trials Unit CRS, Palo Alto
Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis
Bmc Actg Crs, Boston
Washington University Therapeutics (WT) CRS, St Louis
Columbia P&S CRS, New York
Univ. of Texas Medical Branch, ACTU, Galveston
University of Washington AIDS CRS, Seattle
Puerto Rico AIDS Clinical Trials Unit CRS, San Juan
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
NETWORK
National Institute of Allergy and Infectious Diseases (NIAID)
NIH